Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome
Ritsuko Nakai(Sakai Municipal Hospital), Jonathan R. Brestoff(Washington University in St. Louis), Nicholas Borcherding(University of Iowa), Rachael L. Field(Washington University in St. Louis), Russell P. Saneto(Seattle Children's Hospital), Takafumi Yokota(Osaka International Cancer Institute), Hisashi Ohta, Rocky Giwa(Washington University in St. Louis), Wentong Jia(Washington University in St. Louis), Stella Varnum(Washington University in St. Louis), Masashi Suganuma, Eva F. Cohen(Washington University in St. Louis), Rick C. Tsai, Samantha Krysa(Washington University in St. Louis), Henyun Shi(Osaka International Cancer Institute)
Cited by 57
Related Papers
Commensal bacteria at the interface of host metabolism and the immune system
|Nature Immunology|2013|947
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity
|Nature|2014|927
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605